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SummAry Bacillary angiomatosis is a systemic disease caused by 
Bartonella (B.) henselae and B. quintana. Today it is a rare disease that 
occurs predominantly in patients with poor adherence to antiret-
roviral therapy or with late diagnosis of human immunodeficiency 
virus (HIV). We report on the case of a 40-year-old Caucasian female 
with HIV-1 and hepatitis B virus (HBV) co-infection diagnosed 17 
years ago. She presented to the emergency department with an er-
ythematous, painless nodule located on the left naso-genian fold. In 
the next few weeks the disease disseminated to the oral and left tar-
sal mucosa and to the palm of the left hand. The histopathological 
findings were suggestive of bacillary angiomatosis which was con-
firmed by polymerase chain reaction (PCR). The patient was treated 
with clarithromycin 500 mg bid per os for 3 months, with complete 
remission of the mucocutaneous lesions. Bacillary angiomato-
sis is a potentially fatal disease. Early diagnosis and treatment are 
critical in reducing the morbidity and mortality associated with it. 
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InTroduCTIon
Bacillary angiomatosis is a systemic disease caused 
by Bartonella (B.) henselae and Bartonella quintana, 
which are small gram-negative rods in the Bartonella-
ceae family (1). This condition is included in category B 
of the CDC classification for persons infected by human 
immunodeficiency virus (HIV) (2). Its incidence has re-
duced with the use of antiretroviral and prophylactic 
antibiotic therapies (3). Despite representing a rare di-
agnosis in patients with HIV infection on antiretroviral 
therapy, it is still observed in patients with poor adher-
ence to therapy or in patients with late HIV diagnosis. 
CASe rePorT
We report on the case of a 40-year-old Caucasian 
female, former intravenous drug user, with HIV-1 and 
hepatitis B virus (HBV) co-infection diagnosed in 1996, 
with weakened immune status due to non-adherence 
to antiretroviral therapy (ART). In this context, the pa-
tient had a personal history of Salmonella typhimuri-
um sepsis, pneumocystosis (in 2008) and periorbital 
cellulitis (in 2009). Between 2008 and 2010, there was 
a gradual improvement of the immune system and 
a reduction of viral replication under therapy with 
atazanavir/ritonavir, efavirenz, and tenofovir/emtric-
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itabine. Between June 2010 and February 2013, she 
suspended ART. In February 2013 she presented to 
the emergency with an erythematous, painless nod-
ule, 1×1 cm in diameter, with rapid growth in the 
last 15 days, located at the left naso-genian fold (Fig. 
1a). An excisional biopsy was performed and sent to 
histopathological examination with the following di-
agnostic hypotheses: pyogenic granuloma, Kaposi’s 
sarcoma, or bacillary angiomatosis. The hematoxilin-
eosin staining revealed lobular vascular proliferation 
with epitelioid endotelial cells and an inflammatory 
infiltrate with multiple neutrophils (Fig. 2a). The im-
munohistochemistry showed a granular interstitial 
material suggestive of bacillary angiomatosis (Figure 
2b). Bartonella henselae infection was confirmed by 
PCR (Fig. 3). Meanwhile, the patient missed the fol-
low-up visit and it was not possible to establish fur-
ther contact.
One month after the first observation, the pa-
tient presented to the dermatology department due 
to recurrence of erythematous papules on the left 
naso-genian fold. The presence of new erythematous 
papules on the oral and left tarsal mucosa and on the 
palm of the left hand was also observed (Fig. 1b). The 
patient reported no fever, night sweats, chills, pros-
tration, abdominal pain, or diarrhea. She reported be-
ing bitten on the first finger of the right hand by an 
abandoned cat, three weeks before the appearance 
of the first lesion. The patient had started the last an-
tiretroviral regimen on her own when the lesions ap-
peared and was medicated with clarithromycin 500 
mg bid per os for 3 months.
The laboratory assessment performed 3 weeks 
after starting therapy showed: Hb-10.3 g/dL (12-15); 
leukocytes-10.01x109/L (4-11); neutrophils-76.3% (40-
60); platelets-630x109/L(150-450), CD4+-25.9 cells/µL 
[1.6% (29-59)]; HIV viral load-656 copies/ml; GGT-162 
U/L (<38); FA-312 U/L (45-129); CRP-7.99 mg/dL (<0.5); 
anti-Bartonella henselae IgM and IgG were equivocal. 
The chest X-ray revealed no changes. As the patient 
reported no systemic symptoms, she refused to per-
form an abdominal ultrasound to exclude liver and 
spleen involvement. The patient achieved complete 
remission of the mucocutaneous lesions, two months 
after onset of therapy. However, therapy was contin-
ued for another month to reduce recurrences. 
dISCuSSIon
Bartonella infections manifest depending on the 
patient’s immune status and, most likey, strains viru-
lence (3). In immunocompetent persons, B. henselae 
can cause an acute infection called cat scratch dis-
ease, while in immunocompromised patients Barton-
ella species produce a wide range of clinical mani-
festations such as bacillary angiomatosis, peliosis 
hepatitis, splenitis, osteomyelitis, endocarditis, and 
bacteremia (4,5).
Figure 1 a: Bacillary angiomatosis, clinical presenta-
tion: Erythematous, painless, nodule located to the 
left naso-genian fold.
Figure 1b - Bacillary angiomatosis, clinical presentation: Erythematous papules on the oral and left tarsal mu-
cosa and on the palm of the left hand.
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Bacillary angiomatosis is an opportunistic infec-
tion first described in 1983 by Stoler et al. (6). It is 
mainly observed in HIV patients, especially when the 
CD4+ count drops to less than 200 cells/mm3 (1,2), 
and less frequently, in patients with other types of im-
munosuppression (3,5,7,8). Clinical cases have been 
described in immunocompetent patients only rarely 
(1,9).
Epidemiological studies revealed that the most 
common clinical feature of bacillary angiomatosis 
are skin lesions which occur in 55-90% of the patients 
(3). This disease may present with several patterns 
such as: globular angiomatous papules or nodules, 
subcutaneous nodules, large exophytic masses, and 
hyperpigmented indurated plaques on the extremi-
ties (1,7,9). It may be preceded or accompanied with 
constitutional symptoms such as malaise, fever, night 
sweats, headache, cough, anorexia, bloody stool, 
weight loss, and lymphadenopathy (1,2,9). Potentially 
fatal infections with organ involvement, such as: liver, 
spleen, gastrointestinal and respiratory tract, bone, 
bone marrow, and central nervous system infections, 
can also occur (3,5,7). 
It is clinically difficult, but important, to distinguish 
between Kaposi’s sarcoma and bacillary angiomato-
sis (3,7); the latter often has a peeling colarette on the 
basis of the lesions (8). Other diseases that should be 
considered in the differential diagnosis of bacillary 
angiomatosis are: pyogenic granuloma, histiocytoid 
hemangioma, lobular capillary hemangioma, angio-
sarcoma, glomangioma, angiokeratoma, cutaneous 
lymphomas, atypical mycobacteria infections, or his-
toplasmosis (1,7).
 Histopathological examination is essential to con-
firm the diagnosis; and includes findings of circum-
scribed lobular proliferation of small blood vessels 
with “epitelioid” endothelial cells, central necrosis, a 
mixed inflammatory infiltrate with predominance of 
neutrophils, and, occasional, interstitial leukocytocla-
sia of non-ulcerated lobules (1,3,10). Silver staining or 
electron microscopy can show the interstitial granu-
lar material, revealing the bacilli that can also confirm 
the diagnosis (1,7).
In some cases it may be necessary to do other 
tests such as: culture, serology, or molecular methods 
(PCR). In immunocompromised patients, serology 
tests may have low sensitivities due to: cross-reac-
tions between Bartonella sp. and Coxiella burnetii or 
Chlamydia sp., and the inability of these patients in 
producing antibody response (5), as in the case re-
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Figure 3 – Polymerase Chain Reaction study confirmed Bartonella henselae infection.
Figure 2a – Bacillary angiomatosis, histopathologic 
examination: lobular vascular proliferation with epi-
thelioid endotelial cells and an inflammatory infiltrate 
with multiple neutrophils  (H&E 100x)
Figure 2b – Granular interstitial and perivascular ma-
terial suggestive of bacillary angiomatosis (IHQ 100x)
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ported. The treatment of bacillary angiomatosis de-
pends on the infective species, the clinical course, 
and the immunological status of the patient (4). 
Erythromycin 500 mg four times a day or doxycycline 
100 mg twice a day should be the first options (4,10). 
Clarithromycin also showed good efficacy, fewer gas-
trointestinal side effects, (8) and a tissue-serum ratio 
greater than that of erythromycin in the skin after oral 
administration (8). The optimal duration of treatment 
is not yet defined. The cutaneous lesions regress 
completely after one month of therapy (1) and the 
treatment should be maintained for at least 2 months 
(5). In immunodeficient patients it is recommended 
to maintain therapy for 3-4 months, to reduce the risk 
of recurrences (10).
ConCluSIon
Bacillary angiomatosis should be considered in 
the differential diagnosis of angiomatous lesions in 
immunosuppressed patients. Since this is a poten-
tially fatal disease with high morbidity and mortality, 
early diagnosis and treatment are essential to achieve 
a favorable prognosis. 
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